A Leprini - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Leprini

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Cancer|May 15, 1993

In situ lung perfusion with cisplatin. An experimental studyG B Ratto, M Esposito, A Leprini, et al.

Nature Biotechnology|November 14, 1997

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoformD Neri, B Carnemolla, A Nissim, et al.

The Journal of Biological Chemistry|October 6, 1997

Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrinsJ V Moyano, B Carnemolla, C Domínguez-Jiménez, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Cancer|May 15, 1993

In situ lung perfusion with cisplatin. An experimental studyG B Ratto, M Esposito, A Leprini, et al.

Nature Biotechnology|November 14, 1997

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoformD Neri, B Carnemolla, A Nissim, et al.

The Journal of Biological Chemistry|October 6, 1997

Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrinsJ V Moyano, B Carnemolla, C Domínguez-Jiménez, et al.

Pageof 5